药物和聚合物分子在电芯外纳米纤维中的逆梯度分布,用于持续释放
Yaoning Chen1, Wenjian Gong1, Zhiyuan Zhang1
1School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai 200093, China.
International journal of molecular sciences
|September 14, 2024
概括
研究人员使用同轴电旋转开发了新的核心外纳米结构,以改善药物输送. 这些结构通过防止初始爆发和减少尾巴效应来增强持续的药物释放,与传统方法相比,提供了优越的形状.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 制药科学 制药科学
背景情况:
- 核心外纳米结构是先进药物输送系统的关键.
- 同轴电为制造复杂纳米结构提供了一种多功能方法.
- 控制药物释放概况对于治疗疗效至关重要.
研究的目的:
- 制造出新的电芯纳米结构,具有复星 (RES) 和纤维素 (CA) 的反向梯度分布.
- 为了评估这些纳米结构的药物释放行为.
- 提出一种持续释放水溶性较差的药物的机制.
主要方法:
- 通过同轴电制造的核心外纳米结构的制造,使用复星 (RES),纤维素 (CA) 和聚烯 (PVP).
- 使用扫描电子显微镜 (SEM),传输电子显微镜 (TEM),X射线衍射 (XRD) 和里埃变换红外光谱 (FTIR) 的表征.
- 在体外溶解试验以评估药物释放概况.
主要成果:
- 成功制造了具有独特双室结构的线性核心外纳米纤维.
- 已确认组件兼容性和无形分子分布.
- 与混合纳米纤维相比,证明了优越的持续释放配置,防止爆发释放和尾巴效应.
结论:
- 这种具有逆梯度RES/CA分布的新型核心外纳米结构有效控制药物释放.
- 这种方法显著改善了持续药物递送的性能.
- 开发的平台可以创建具有量身定制的释放特征的先进功能纳米材料.
相关概念视频
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


